Originally published as JCO Early Release 10.1200/JCO.2008.19.7970 on April 20 2009

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dai, Q. Articles by Zheng, W. Search for Related Content PubMed PubMed Citation Articles by Dai, Q. Articles by Zheng, W. Social Bookmarking                            What's this?

Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study

From the Departments of Medicine and Pharmacology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, School of Medicine, Vanderbilt University, Nashville, TN; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China; and Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Corresponding author: Qi Dai, MD, PhD, Vanderbilt Epidemiology Center, Institute for Medicine and Public Health, 2525 West End Ave, Sixth Floor, Suite 600, Nashville, TN 37203-1738; e-mail: qi.dai{at}vanderbilt.edu.

Purpose Increased reactive oxygen species may exhaust the antioxidant capability of human defense systems, leading to oxidative stress and cancer development. Urinary F2-isoprostanes, secondary end products of lipid peroxidation, are more accurate markers of oxidative stress than other available biomarkers. No prospective study has investigated whether levels of 15-F_2t-isoprostane (15-F_2t-IsoP) and its metabolite 2,3-dinor-5,6-dihydro-15-F_2t-IsoP (15-F_2t-IsoPM) are related to breast cancer risk.

Patients and Methods We conducted a nested case-control study within the Shanghai Women's Health Study, a population-based cohort study of 74,942 Chinese women between 40 and 70 years of age. Prediagnostic urinary 15-F_2t-IsoP and 15-F_2t-IsoPM were measured by gas chromatography mass spectrometry for 436 breast cancer cases and 852 individually matched controls.

Results Urinary excretion of isoprostanes was not significantly different between cases and controls. However, among overweight women, levels of isoprostanes were positively associated with breast cancer risk, which became stronger with increasing body mass index (BMI). Among women with a BMI 29, the odds ratio (OR) increased to 10.27 (95% CI, 2.41 to 43.80) for the highest compared with the lowest tertile of 15-F_2t-IsoPM (P for trend = .003; P for interaction = .0004). In contrast, 15-F_2t-IsoP and 15-F_2t-IsoPM were inversely associated with breast cancer risk among nonoverweight women. Among women with a BMI 23, breast cancer risk was reduced with increasing 15-F_2t-IsoP levels in a dose-response manner (P for trend = .006), with an OR of 0.46 (95% CI, 0.26 to 0.80) for the highest tertile versus the lowest (P for interaction = .006).

Conclusion Our results suggest that the role of oxidative stress in breast cancer development may depend on adiposity.

Supported by Grant No. R01CA106591 from the National Institutes of Health (Q.D.) as well as Grants No. R01CA70867 from the National Institutes of Health (W.Z.) and N02 CP1101066 from the National Institutes of Health Intramural Program (X.O.S.) for the parent study.

The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?